| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Methotrexate | FIMM | pan-cancer | AAC | -0.021 | 0.9 |
| mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | -0.0081 | 0.9 |
| mRNA | paclitaxel | GDSC1000 | pan-cancer | AAC | 0.008 | 0.9 |
| mRNA | isoevodiamine | CTRPv2 | pan-cancer | AAC | -0.0048 | 0.9 |
| mRNA | Obatoclax Mesylate | CTRPv2 | pan-cancer | AAC | -0.0048 | 0.9 |
| mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | -0.004 | 0.9 |
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | -0.0043 | 0.9 |
| mRNA | KPT185 | CTRPv2 | pan-cancer | AAC | -0.0051 | 0.9 |
| mRNA | BRD-K27986637 | CTRPv2 | pan-cancer | AAC | 0.0098 | 0.9 |
| mRNA | navitoclax:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0045 | 0.9 |